These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3021285)

  • 1. Kappa opioid receptor-mediated analgesia in the developing rat.
    Barr GA; Paredes W; Erickson KL; Zukin RS
    Brain Res; 1986 Oct; 394(2):145-52. PubMed ID: 3021285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine- and ketocyclazocine-induced analgesia in the developing rat: differences due to type of noxious stimulus and body topography.
    Giordano J; Barr GA
    Brain Res; 1987 Apr; 429(2):247-53. PubMed ID: 3032373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human psychopharmacology of ketocyclazocine as compared with cyclazocine, morphine and placebo.
    Kumor KM; Haertzen CA; Johnson RE; Kocher T; Jasinski D
    J Pharmacol Exp Ther; 1986 Sep; 238(3):960-8. PubMed ID: 3018228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple opiate receptors: [3H]ethylketocyclazocine receptor binding and ketocyclazocine analgesia.
    Pasternak GW
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3691-4. PubMed ID: 6251477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dose-ratio comparison of mu and kappa agonists in formalin and thermal pain.
    Abbott FV; Franklin KB; Libman RB
    Life Sci; 1986 Nov; 39(21):2017-24. PubMed ID: 3023775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal kappa-opioid receptor-mediated antinociception is stimulus-specific.
    Schmauss C
    Eur J Pharmacol; 1987 Jun; 137(2-3):197-205. PubMed ID: 2886350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic actions of mu- and kappa-opiate agonists in rats.
    Upton N; Sewell RD; Spencer PS
    Arch Int Pharmacodyn Ther; 1983 Apr; 262(2):199-207. PubMed ID: 6135397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mu- and kappa-opiate agonists modulate ingestive behaviors in the slug, Limax maximus.
    Kavaliers M; Rangeley RW; Hirst M; Teskey GC
    Pharmacol Biochem Behav; 1986 Mar; 24(3):561-6. PubMed ID: 3010335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mu opiate isoreceptors: differentiation with kappa agonists.
    Wood PL; Richard JW; Thakur M
    Life Sci; 1982 Nov 15-22; 31(20-21):2313-7. PubMed ID: 6131359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists.
    Eisenberg RM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):863-9. PubMed ID: 2989500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential tolerance and cross-tolerance to chronic treatment with mu and kappa opioid agonists in the rat.
    Young GA; Khazan N
    NIDA Res Monogr; 1984 Mar; 49():121-7. PubMed ID: 6090915
    [No Abstract]   [Full Text] [Related]  

  • 12. Similar anticonvulsant, but unique, behavioural effects of opioid agonists in the seizure-sensitive Mongolian gerbil.
    Lee RJ; Bajorek JG; Lomax P
    Neuropharmacology; 1984 May; 23(5):517-24. PubMed ID: 6330606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Food hoarding and ingestion in the deer mouse, Peromyscus maniculatus: selective responses to mu and kappa opiate agonists.
    Kavaliers M; Hirst M
    Pharmacol Biochem Behav; 1986 Sep; 25(3):543-8. PubMed ID: 3022306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of opiate agonists on day-night feeding rhythms in young and old mice.
    Kavaliers M; Hirst M
    Brain Res; 1985 Feb; 326(1):160-7. PubMed ID: 2982458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal analgesia: comparison of the mu agonist morphine and the kappa agonist ethylketazocine.
    Wood PL; Rackham A; Richard J
    Life Sci; 1981 May; 28(19):2119-25. PubMed ID: 6114371
    [No Abstract]   [Full Text] [Related]  

  • 17. Concerning the specificity of the hypothalamic opiate receptor responsible for food intake in the rat.
    Tepperman FS; Hirst M
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1141-4. PubMed ID: 6298827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential tolerance and cross-tolerance to repeated daily injections of mu and kappa opioid agonists in the rat.
    Young GA; Khazan N
    Neuropharmacology; 1984 May; 23(5):505-9. PubMed ID: 6330605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of ketocyclazocine antinociception in rats by perinatal lead exposure.
    Kitchen I; McDowell J
    Toxicol Lett; 1985 Aug; 26(2-3):101-5. PubMed ID: 2994261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.